Phibro Animal Health | PAHC - Current Liabilities


Phibro Animal Health reported $281.87M in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
Align Technology USD 1.91B 2.74M Jun/2026
ANI Pharmaceuticals USD 283.65M 44.14M Jun/2026
Aurora Cannabis CAD 66.93M 79M Mar/2026
Bristol-Myers Squibb USD 18.66B 499M Jun/2026
Canopy Growth CAD 158.44M 60.15M Mar/2026
Corcept Therapeutics USD 153.8M 4.62M Jun/2026
Eli Lilly USD 47.74B 11.11B Jun/2026
Henry Schein USD 3.49B 191M Jun/2026
Idexx Laboratories USD 1.29B 12.19M Jun/2026
Knight Therapeutics CAD 165.26M 12.58M Dec/2025
Merck USD 27.73B 786M Jun/2026
Nektar Therapeutics USD 57.71M 4.17M Mar/2026
Pacira USD 122.01M 13.22M Jun/2026
Phibro Animal Health USD 281.87M 500K Mar/2026
Prestige Brands USD 153.81M 32.88M Jun/2026
Supernus Pharmaceuticals USD 347.38M 26.55M Jun/2026
Zoetis USD 2.06B 8M Jun/2026